UPDATE — Foamix Receives FDA Approval of AMZEEQ™ Topical Minocycline Treatment for Millions of Moderate to Severe Acne Sufferers
/
Date20 Oct 2019
Email Print Friendly Share AMZEEQ is the First-ever FDA Approved Topical Form of Minocycline AMZEEQ Offers Efficacy with Low Systemic Absorption REHOVOT, Israel and BRIDGEWATER, N.J., Oct. 18,... Read More →
MJardin Group Provides Update on Cannabella Acquisition
/
Date19 Oct 2019
Email Print Friendly Share TORONTO and DENVER, Oct. 18, 2019 (GLOBE NEWSWIRE) — MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a... Read More →
Kidney Community Loses a Great Friend and Powerful Advocate in Elijah Cummings
/
Date18 Oct 2019
Email Print Friendly Share ROCKVILLE, Md., Oct. 17, 2019 (GLOBE NEWSWIRE) — American Kidney Fund (AKF) president and CEO LaVarne A. Burton issued the following... Read More →
Sunesis Pharmaceuticals Announces Presentation of SNS-510 Preclinical Data at the 2019 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
/
Date17 Oct 2019
Email Print Friendly Share SOUTH SAN FRANCISCO, Calif., Oct. 16, 2019 (GLOBE NEWSWIRE) — Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced a poster presentation at... Read More →
Allsup Offers Alternative Healthcare Solutions at 2019 IFEBP Employee Benefits Conference
/
Date16 Oct 2019
Email Print Friendly Share Belleville, Illinois, Oct. 15, 2019 (GLOBE NEWSWIRE) — Allsup, the nation’s premier advocacy firm providing guidance on alternative healthcare options for... Read More →
Akorn Receives FDA Approval for Betamethasone Dipropionate Lotion USP (Augmented), 0.05%
/
Date15 Oct 2019
Email Print Friendly Share LAKE FOREST, Ill., Oct. 14, 2019 (GLOBE NEWSWIRE) — Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that it... Read More →
Les résultats de l’étude de la tésamoréline pour la stéatose hépatique non-alcoolique publiés dans le Lancet HIV
/
Date14 Oct 2019
Email Print Friendly Share MONTRÉAL, 11 oct. 2019 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX) est heureuse d’annoncer que les résultats d’un... Read More →
Tesamorelin Study Results on NAFLD Published in Lancet HIV
/
Date13 Oct 2019
Email Print Friendly Share MONTREAL, Oct. 11, 2019 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX) is pleased to announce that results from... Read More →
Adverum Biotechnologies Reports Additional Clinical Data from First Cohort of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at the American Academy of Ophthalmology 2019 Annual Meeting
/
Date12 Oct 2019
Email Print Friendly Share — Zero anti-VEGF rescue injections required in the first cohort and durable efficacy with median follow up of 34 weeks —— Sequential... Read More →
New Head-to-Head Data Show TALTZ® (ixekizumab) Superiority versus TREMFYA® (guselkumab) in People with Moderate to Severe Plaque Psoriasis
/
Date11 Oct 2019
Email Print Friendly Share TALTZ met the primary endpoint of the IXORA-R study, with 41.3 percent of patients taking TALTZ achieving complete skin clearance as... Read More →